At new center, Purdue engineers will collaborate with IU doctors
Purdue University’s new Center for Musculoskeletal Engineering in Indianapolis has a growth plan that metaphorically matches a healthy growing body.
Purdue University’s new Center for Musculoskeletal Engineering in Indianapolis has a growth plan that metaphorically matches a healthy growing body.
Local and federal funds, special state appropriations, private and philanthropic investments, and innovative value-capture mechanisms must all be considered.
Heartland BioWorks was designated as a federal technology hub by the U.S. Department of Commerce in October 2023 to support growth in biomanufacturing innovation and workforce development.
The Indianapolis-based drugmaker said the supercomputer will power an “AI factory” designed to accelerate drug discovery and development.
Indianapolis-based Eli Lilly and Co. said the improved facility in Carolina, Puerto Rico, will make orforglipron, Lilly’s highly anticipated weight loss pill.
Through its LillyDirect pharmacy, Eli Lilly plans to offer steep discounts on single-dose vials of Zepbound by partnering with the nation’s largest retail chain.
With quarterly revenue up 54% from a year ago, Eli Lilly raised it guidance for the year, with the company now expecting revenue in the range of $63 billion to $63.5 billion.
City leaders, local companies and food banks have teamed up to create a $1 million-plus partnership and fundraising push to help more than 200 food pantries in Indianapolis.
Eli Lilly and Co. is funding and participating in an Indiana University study that examines the health outcomes of people on weight loss drugs, including Lilly medications.
The rise of artificial intelligence is not only affecting how people work—it’s also shaping the job market itself, especially for graduates in search of their first professional jobs.
The facility is expected to produce oral medications, including Lilly’s highly anticipated GLP-1 pill for weight loss, orforglipron.
The deal is seen as one of the most significant in the administration’s current drug-pricing push, given the potential effect on public health and spending on health care.
Despite reporting a loss, the company saw quarterly growth in the double digits and raised its full-year earnings estimate.
Thursday’s announcement is the latest attempt by the Trump administration to rein in soaring drug prices in its efforts to address cost-of-living concerns among voters.
The reduced SNAP benefits delay and delay in providing them—not to mention the 24,000 federal workers in Indiana who are going without paychecks—mean there will be families who need help.
The announcement comes on the heels of a deal with the Trump administration to expand access to weight-loss drugs and reduce costs for patients on government-funded insurance and those paying out of pocket.
Lilly’s shares have taken off in the wake of several significant deals and after it received fast-track regulatory review for highly anticipated weight-loss pill orforglipron.
David Ricks, speaking Thursday during a panel at the annual BioCrossroads Life Sciences Summit, also called for Purdue and Indiana universities to upgrade their lab facilities.
We need a grassroots revolution in meeting the needs of our neighbors.
Sonny Beck, CEO of Atlanta-based Beck’s Hybrids, led the push to land a U.S. Customs and Border Protection office at Indianapolis Executive Airport.